Infectious diseases

Hospital Acquired Infection Control Market Analysis Report 2021-2028 by Type (Equipment, Services, Consumables), by End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 4, 2021
Infectious Diseases, Hospitals, Health, Health, Medical specialties, Infectious diseases, Epidemiology, Occupational safety and health, Healthcare-associated infections, Hospital-acquired infection, COVID-19, Infection prevention and control, Infection, Surgery

The "Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report by Type (Equipment, Services, Consumables), by End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers), by Region and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report by Type (Equipment, Services, Consumables), by End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers), by Region and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The key factors driving the market growth include the rising incidence of Hospital Acquired Infections (HAIs), supportive government initiatives and the COVID-19 pandemic.
  • The demand for infection control equipment and consumables also stemmed from the need to stop the spread of COVID-19.
  • The company was merged into Getinge's Infection Control portfolio to expand its offerings in the business area of Surgical Workflows
    Chapter 3 Hospital Acquired Infection Control Market Variables, Trends & Scope

New Study Shows Daily Supplementation with Pycnogenol® May Provide Relief from Recurrent Urinary Tract Infections

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Clinical medicine, Infectious diseases, Medicine, Urinary tract infection, Urinary retention, Urinary incontinence, Urologic disease

Recurrent urinary tract infections are the result of a bacterial infection and defined as three episodes in the previous year or two episodes in the last six months.

Key Points: 
  • Recurrent urinary tract infections are the result of a bacterial infection and defined as three episodes in the previous year or two episodes in the last six months.
  • About 50 percent of women worldwide contract at least one urinary tract infection in their lifetime and 2530 percent of women have at least one episode of recurrent urinary infections.
  • Around 12 percent of men1 will experience urinary tract infections in their lifetime.
  • Urinary tract infections cause up to 10 million visits2 to health care providers each year.

Seoul Viosys Reports Record-High Second Quarter 2021 Results

Retrieved on: 
Wednesday, August 4, 2021
Other Manufacturing, Technology, Infectious diseases, Semiconductor, Nanotechnology, Manufacturing, Hardware, Health, Science, Other Science, Yoy

Seoul Viosys Co., Ltd. (Seoul) (KOSDAQ 092190), a leading global compound semiconductor provider, today announced its all-time high second quarter earnings results 2021 with revenues of KRW 131.6 billion and operating profit of KRW 11.2 billion (operating margin of 8.5%) on a consolidated basis.

Key Points: 
  • Seoul Viosys Co., Ltd. (Seoul) (KOSDAQ 092190), a leading global compound semiconductor provider, today announced its all-time high second quarter earnings results 2021 with revenues of KRW 131.6 billion and operating profit of KRW 11.2 billion (operating margin of 8.5%) on a consolidated basis.
  • Second quarter consolidated revenue and operating profit increased by 27% YoY and by 84% YoY respectively.
  • The company suggests sales are expected to continue further growth, increasing by 7% to 16% YoY for the third quarter 2021.
  • For the visible segment of the company, WICOP, which offers package-less LED solutions designed with a robust structure, achieved a 68% YoY growth in second quarter 2021 and led to total revenue and profit growth.

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

Retrieved on: 
Tuesday, August 3, 2021
Biotechnology, FDA, Health, Other Health, Pharmaceutical, Other Education, Continuing, Other Science, University, Research, Infectious diseases, Education, General Health, Science, Branches of biology, Molecular biology, Biology, Articles, Biotechnology, Laboratory techniques, Amplifiers, Polymerase chain reaction, Roche, Applied DNA Sciences, COVID-19 testing, Polymerase, safeCircle™, the Linea™ COVID-19 Assay Kit, Applied DNA Sciences, SAFECIRCLE™, THE LINEA™ COVID-19 ASSAY KIT, APPLIED DNA SCIENCES

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced that its wholly-owned subsidiary, Applied DNA Clinical Labs, LLC, (ADCL) was awarded a competitively-bid COVID-19 testing contract by the City University of New York ( CUNY ) Board of Trustees to facilitate the Universitys reopening in the fall (the Contract).

Key Points: 
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced that its wholly-owned subsidiary, Applied DNA Clinical Labs, LLC, (ADCL) was awarded a competitively-bid COVID-19 testing contract by the City University of New York ( CUNY ) Board of Trustees to facilitate the Universitys reopening in the fall (the Contract).
  • The Contract term is 12 months, has a maximum value not to exceed $35.0 million, and contains no minimum weekly testing commitment.
  • CUNY projects weekly testing in the range of 20,000 to 65,000 tests over the period of the Contract.
  • Testing levels are contingent on vaccination rates, the ratio of in-person versus remote attendance, and positivity rates within the CUNY population.

USDA Urges New York Residents to Check Trees for Asian Longhorned Beetle and to Not Move Untreated Firewood

Retrieved on: 
Tuesday, August 3, 2021
Veterinary, Natural Resources, General Health, Health, FDA, Infectious diseases, Forest Products, Other Health, Insects, Insects in culture, Hexapoda, Arthropods, Lamiini, Asian long-horned beetle, Invasive species, Pest, Longhorn beetle, Beetle

August is the most critical time of year to spot the Asian longhorned beetle (ALB) as adult activity peaks.

Key Points: 
  • August is the most critical time of year to spot the Asian longhorned beetle (ALB) as adult activity peaks.
  • Thats why the U.S. Department of Agriculture (USDA) is declaring August as Tree Check Month for this invasive pest.
  • Checking trees for the beetle and the damage it causes is how residents can help USDA and its partners eliminate the beetle from the United States, and protect more trees.
  • This invasive pest continues to be found on Long Island in New York, so residents need to be on watch.

Haymarket Medical Network Launches Rare Disease Advisor

Retrieved on: 
Tuesday, August 3, 2021
Other Communications, Infectious diseases, Publishing, Marketing, Advertising, Communications, Other Health, Health, General Health, Rare disease, HCPS, Medicine, Rare diseases

Haymarket Medical Network today launched Rare Disease Advisor, a new digital resource for healthcare professionals (HCPs) to help them recognize, diagnose, refer and treat rare diseases.

Key Points: 
  • Haymarket Medical Network today launched Rare Disease Advisor, a new digital resource for healthcare professionals (HCPs) to help them recognize, diagnose, refer and treat rare diseases.
  • The sites thorough approach to covering rare disease news and perspectives will also benefit patients by providing them with up-to-date and relevant information that allows them to advocate for themselves and their families.
  • "Patients suffering from rare medical conditions often struggle to be properly diagnosed.
  • I am excited that Rare Disease Advisor will inform HCPs on the innovative therapies being developed and help connect underserved patients to treatment, said Mike Graziani, President, Haymarket Medical Communications Group.

Southeast Asia Facilities Management Market Business Models and Growth Opportunities Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021
Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Contemporary history, Southeast Asia, COVID-19 pandemic, Articles, Infectious diseases

The "Southeast Asia Facilities Management Emerging Business Models and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Southeast Asia Facilities Management Emerging Business Models and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • This study presents an updated revenue forecast of the FM market in Southeast Asia, covering Malaysia, Indonesia, Singapore, Thailand, Vietnam, and the Philippines.
  • Growth opportunities identified in the Southeast Asian FM market include smart services for COVID-19 mitigation, innovative business models for new services propositions, and crowd analytics for enhanced FM security services.
  • FM market participants in Southeast Asia must strategize to rebound from the COVID-19 pandemic in the next 1-2 years.

Millennials drive DTC cross-border e-commerce growth as pandemic prompts 52% to buy online directly from international brands

Retrieved on: 
Tuesday, August 3, 2021
Retail, Consumer electronics, Other Health, Technology, Other Consumer, Women, Online Retail, Infectious diseases, Teens, Other Retail, MEN, Family, Consumer, Health, Fashion, Retailing, Retailers, Articles, Non-store retailing, E-commerce, Electronics industry, Supply chain management, Millennials, Brand, Shoppers Drug Mart

Millennials have driven the rise in international direct-to-consumer (DTC) e-commerce purchases in the last six months, with reduced access to stores during the pandemic prompting over half (52%) of 2534-year-olds to buy online directly from international brands, the latest data from eShopWorld (ESW) reveals.

Key Points: 
  • Millennials have driven the rise in international direct-to-consumer (DTC) e-commerce purchases in the last six months, with reduced access to stores during the pandemic prompting over half (52%) of 2534-year-olds to buy online directly from international brands, the latest data from eShopWorld (ESW) reveals.
  • ESWs Global Voices: Pre-Peak Pulse 2021 survey of almost 15,000 consumers across 14 countries showed that 52% of shoppers overall were motivated to buy online during the pandemic.
  • Reduced access to stores also boosted cross-border e-commerce, with almost half (46%) of global shoppers surveyed saying it prompted them to buy directly from an international brand online, rising to 52% among those ages 2534.
  • Consumers in India and China (both 61%), Mexico (59%) and Russia (50%) were the most likely to have purchased directly from an international brand online in the first half of 2021.

Optime Care Offers Patient-First Humatin Total Care Program, Maximizes Therapeutic Benefits of Humatin™ for Hepatic Encephalopathy

Retrieved on: 
Tuesday, August 3, 2021
Practice Management, Pharmaceutical, Managed care, Health, Data management, Infectious diseases, Hospitals, Technology, Brain disorders, Medical specialties, Anatomy, Branches of biology, Hepatology, Coma, Hepatic encephalopathy, Encephalopathy, Orphan drugs, Paromomycin, Liver

Optime Care , a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces the availability of Humatin (paromomycin sulfate) exclusively through Humatin Total Care .

Key Points: 
  • Optime Care , a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces the availability of Humatin (paromomycin sulfate) exclusively through Humatin Total Care .
  • Humatin Total Care enables physicians to maximize the therapeutic opportunity for treating hepatic encephalopathy.
  • In the most severe form of hepatic encephalopathy, affected individuals may develop marked confusion or disorientation, amnesia, stupor or coma.
  • Quill concludes, As part of our patient-first focus, Humatin Total Care helps every stakeholder group impacted by this disease.